New AI Imaging Detects ‘Striking’ Obesity-Related Neuropathy David Brzostowicki July 08, 2026

https://www.medscape.com/viewarticle/new-ai-imaging-detects-striking-obesity-related-neuropathy-2026a1000mzo GLP-1 receptor agonists are being prescribed to tens of millions of patients with obesity. What no one can yet answer is whether those drugs are protecting their peripheral nerves or damaging them further. Small clinical studies suggest GLP-1 receptor agonists may improve nerve structure in patients with diabetic neuropathy, yet other studies document cases where patients develop peripheral neuropathy because of rapid weight loss due to GLP-1 drugs.